Advisors

The ABTA relies on leaders in the brain tumor community to make sure the work we do is meaningful and accurate. Our Scientific Advisory Council makes research funding recommendations to the ABTA board of directors, and also advises the ABTA about scientific trends and new areas of research. Our Clinical Advisory Council reviews our publications and other content we put out to make sure everything is clinically up to date.


Scientific Advisory Council

Peter C. Burger, MD
Professor of Pathology, Neurosurgery, Oncology


Johns Hopkins University Hospital


Baltimore, Maryland

Webster K. Cavenee, PhD
Director of Strategic Alliances in Central Nervous System Cancers, Ludwig Institute for Cancer Research


University of California, San Diego


San Diego, California

E. Antonio Chiocca, MD, PhD
Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School; Neurosurgeon-in-Chief and Chairman, Department of Neurosurgery; Co-Director, Institute for the Neurosciences at the Brigham Brigham and WomenÕs/Faulkner Hospital Surgical Director, Center for Neuro-Oncology


Brigham and WomenÕs and Dana-Farber Cancer Institute


Boston, Massachusetts

Henry S. Friedman, MD
Professor of Neurosurgery, James B. Powell, Jr. Professor of Pediatric Oncology, Assistant Professor of Pathology, Associate Professor of Medicine, Professor of Pediatrics, The Preston Robert Tisch Brain Tumor Center


Duke University Medical Center


Durham, North Carolina

G. Yancey Gillespie, PhD
Professor of Surgery, Microbiology, Cell Biology; Co-Director of the UAB Brain Tumor SPORE


University of Alabama at Birmingham


Birmingham, Alabama

William Hahn, MD, PhD
Professor of Medicine, Harvard Medical School; Director, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; Chief, Division of Molecular and Cellular Oncology, Medical Oncology; Professor of Medicine, Medical Oncology, Dana-Farber Cancer Institute


Harvard Medical School and Dana-Farber Cancer Institute


Boston, Massachusetts

en English
X